MedPath

Integrative and Complementary Health Practices (PICS)

Not Applicable
Recruiting
Conditions
Neoplasms
Epilepsy
Registration Number
NCT04152109
Lead Sponsor
Universidade Federal do Triangulo Mineiro
Brief Summary

Complementary medicine, considered an unconventional approach, is performed in conjunction with conventional medicine. In Brazil, Integrative and Complementary Practices in Health have been inserted by the National Ordinance of Integrative and Complementary Practices. The aim of this study is to evaluate the effects of laying on of hands with spiritual connection by the Spiritist Passe about mental and physical health and quality of life of individuals.

Detailed Description

Type of study: randomized controlled trial. The sample will consist of cancer and epileptic patients including individuals aged eigtheen years and over. Patients will be referred by health professionals and social workers from Lar da Charidade, Clinics Hospital and attachments, as well as from the general community and will be invited to participate in the study at the Center for Integrative and Complementary Practices of the Clinics Hospital.

Participants will answer the questionnaires before the start of the study, after eight sessions and fiveteen days or the end of the research according to the group. The participants will be submitted to blood collection, when necessary.

Recruitment & Eligibility

Status
RECRUITING
Sex
All
Target Recruitment
60
Inclusion Criteria
  • Cancer patients: diagnosis of neoplasia receiving parenteral chemotherapy.
  • Epileptic patients: clinical diagnosis of focal epilepsy
Exclusion Criteria
  • Cancer patients: pregnant women, unable to understand the questionnaires; non-attendance of 3 sessions of therapy application and refusal to sign the consent form.
  • Epileptic patients: people unable to understand the questionnaires; non-attendance of 3 sessions of therapy application and refusal to sign the consent form, as well as special groups (pregnant women, newly diagnosed epilepsy).

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Primary Outcome Measures
NameTimeMethod
DepressionChange from Baseline the results anxiety at 8 weeks and maintained at 10 weeks.

Evaluation of Depression by by Depression, Anxiety and Stress Scale. Scores between 0-63. Higher score indicates greater severity.

AnxietyChange from Baseline the results anxiety at 8 weeks and maintained at 10 weeks.

Evaluation of Anxiety by Depression, Anxiety and Stress Scale. Scores between 0-63. Higher score indicates greater severity.

StressChange from Baseline the results anxiety at 8 weeks and maintained at 10 weeks.

Evaluation of stress by Depression, Anxiety and Stress Scale. Scores between 0-63. Higher score indicates greater severity.

Secondary Outcome Measures
NameTimeMethod
Fatigue cancer patientsChange from Baseline the results anxiety at 8 weeks and maintained at 10 weeks.

Functional Assessment of Chronic Illness Scale. Higher score on the scale indicates greater fatigue level.

Quality of life in cancer patientsChange from Baseline the results anxiety at 8 weeks and maintained at 10 weeks.

Questionnaire developed to assess the quality of life of cancer patients. Lower score by scale indicates poorer quality of life.

Analysis of bloodChange from Baseline the results anxiety at 8 weeks and maintained at 10 weeks.

Blood collection for complete blood count.

Assessment of blood pressureChange from Baseline the results anxiety at 8 weeks and maintained at 10 weeks.

Blood pressure, measured by the BPA 100 Microlife automatic oxygenation device

Assessment of peripheral oxygen saturationChange from Baseline the results anxiety at 8 weeks and maintained at 10 weeks.

Peripheral oxygen saturation by the fingertip handheld pulse oximeter

Fatigue in epileptic and cancer patientsChange from Baseline the results anxiety at 8 weeks and maintained at 10 weeks.

Fatigue in epileptic and cancer patients by Fatigue pictogram. Scores between 0 - 4.

Assessment of heart rateChange from Baseline the results anxiety at 8 weeks and maintained at 10 weeks.

Heart rate (HR) by the fingertip handheld pulse oximeter.

Quality of life in epileptic patientsChange from Baseline the results anxiety at 8 weeks and maintained at 10 weeks.

Quality of life in epileptic patients by EQ-5D

Brain electrical activity in epileptic patientsChange from Baseline the results anxiety at 8 weeks.

Assessment of brain electrical activity in epileptic patients by electroencephalogram.

Pain intensityChange from Baseline the results anxiety at 8 weeks and maintained at 10 weeks.

Assessment of pain by Visual pain scale (VAS). Scores between 0 - 10. High scores indicates worse pain intensity.

Autonomic Response in epileptic patientsChange from Baseline the results anxiety at 8 weeks.

Assessment of Heart rate variability by electrocardiogram with assessment of heart rate variability.

Trial Locations

Locations (1)

Núcleo de Praticas Integrativas e Complementares

🇧🇷

Uberaba, Minas Gerais, Brazil

Núcleo de Praticas Integrativas e Complementares
🇧🇷Uberaba, Minas Gerais, Brazil
© Copyright 2025. All Rights Reserved by MedPath